Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is evaluated if the Botulinum Toxin Type A is superior to 0,9%
saline in treatment of cranial Allodynia in patients with headache.
Hypothesis
H(0): Botulinum Toxin Type A is not superior to 0,9% saline in treatment of cranial Allodynia
in patients with headache
H (1): Botulinum Toxin Type A is superior to 0,9% saline in treatment of cranial Allodynia in
patients with headache
Phase:
Phase 3
Details
Lead Sponsor:
Federal University of Bahia
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA Polystyrene sulfonic acid